바이오크리스트 (BCRX)

Biocryst Pharmaceuticals Inc. (BCRX) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	7.68% 93.40	86.74	82.49	68.78	79.55
Cost Of Revenue	41.67% 1.557	1.099	0.894	0.931	2.383
Gross Profit	7.24% 91.84	85.64	81.60	67.85	77.16
Operating Expenses	37.87% 134.51	97.56	102.30	96.26	123.47
Interest Income/Expense	10.10% 24.58	27.34	28.91	27.40	26.46
Benefits Costs and Expenses	27.74% 156.56	122.56	157.08	121.44	151.01
Costs And Expenses	37.91% 136.07	98.66	103.19	97.19	125.86
Operating Income/Loss	257.94% -42.67	-11.92	-20.70	-28.41	-46.31
Income/Loss From Continuing Operations Before Tax	76.34% -63.16	-35.82	-74.59	-52.66	-71.47
Income Tax Expense/Benefit	533.64% -1.431	0.33	0.74	0.671	0.076
Income/Loss From Continuing Operations After Tax	70.77% -61.73	-36.15	-75.33	-53.33	-71.54
Net Income/Loss	70.77% -61.73	-36.15	-75.33	-53.33	-71.54
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	98.36% 3.103	189.64	189.12	188.51	0.342
Diluted Average Shares	98.36% 3.103	189.64	189.12	188.51	0.342
Basic Earnings Per Share	63.16% -0.31	-0.19	-0.40	-0.28	-0.38
Diluted Earnings Per Share	63.16% -0.31	-0.19	-0.40	-0.28	-0.38
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-